- Hormones Regulating Plasma Calcium Levels – PTH, Calcitonin, Vitamin D maintain calcium homeostasis.
- Hormones Regulating Plasma Calcium Levels – PTH, Calcitonin, Vitamin DPTH, Calcitonin, and Vitamin D regulate calcium absorption, reabsorption, and bone resorption.
- Calcium homeostasis is maintained by the interplay of PTH, calcitonin, and vitamin D, each of which can be targeted pharmacologically.
Parathyroid Hormone (PTH)/ Parathormone
Physiology:
- Secreted by parathyroid chief cells in response to low calcium.
- Increases serum calcium by:
- Stimulating osteoclast activity via osteoblast signaling.
- Increasing renal calcium reabsorption.
- Activating vitamin D to enhance intestinal calcium absorption.
Pharmacology:
- PTH Analogues:
- Teriparatide (PTH 1–34):
- Uses: Osteoporosis (stimulates bone formation).
- Adverse Effects: Hypercalcemia, potential osteosarcoma (animal studies).
- Teriparatide (PTH 1–34):
- PTH Inhibitors:
- Calcimimetics (e.g., Cinacalcet):
- Uses: Secondary hyperparathyroidism in CKD, parathyroid carcinoma.
- Mechanism: Increases calcium receptor sensitivity, reducing PTH secretion.
- Calcimimetics (e.g., Cinacalcet):
Calcitonin
Physiology:
- Secreted by thyroid parafollicular (C) cells in response to high calcium.
- Lowers calcium by inhibiting osteoclast-mediated bone resorption and reducing renal calcium reabsorption.
Pharmacology:
- Salmon Calcitonin:
- Uses: Hypercalcemia, Paget’s disease, osteoporosis (less common).
- Adverse Effects: Hypersensitivity, nausea, flushing.
Vitamin D
Physiology:
- Obtained as cholecalciferol (D3) from skin or ergocalciferol (D2) from diet.
- Hydroxylated in liver (25-OH D) and kidney (1,25-(OH)2 D or calcitriol).
- Enhances calcium and phosphate absorption and promotes bone mineralization.
Pharmacology:
- Vitamin D Analogues:
- Calcitriol (active form):
- Uses: Hypocalcemia, osteoporosis, rickets, osteomalacia.
- Adverse Effects: Hypercalcemia, hypercalciuria.
- Calcitriol (active form):
- Synthetic Analogues (e.g., Paricalcitol, Alfacalcidol):
- Uses: Secondary hyperparathyroidism in CKD.
- Mechanism: Similar to calcitriol, with variations in potency and kinetics.
Clinical Applications
- Osteoporosis: Treated with teriparatide or calcitriol.
- Hypercalcemia: Managed with calcitonin.
- Hypocalcemia/Rickets: Corrected with vitamin D analogues.
- Secondary Hyperparathyroidism: Controlled with calcimimetics or synthetic vitamin D analogues.
Side Effects
- Teriparatide: Hypercalcemia, leg cramps, nausea.
- Salmon Calcitonin: Nausea, flushing, allergic reactions.
- Calcitriol: Hypercalcemia, hypercalciuria, kidney stones.
Thank you for reading from Firsthope's notes, don't forget to check YouTube videos!